Cargando…
Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin
BACKGROUND: Bosentan is a dual endothelin receptor antagonist initially introduced for the treatment of pulmonary arterial hypertension and recently approved for the treatment of digital ulcers in patients with systemic sclerosis (SSc). Our clinical observations indicate that bosentan therapy may be...
Autores principales: | Hetzer, Sonja, Buhren, Bettina Alexandra, Schrumpf, Holger, Bölke, Edwin, Meller, Stephan, Kammers, Kai, Gerber, Peter Arne, Homey, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902062/ https://www.ncbi.nlm.nih.gov/pubmed/24410934 http://dx.doi.org/10.1186/2047-783X-19-2 |
Ejemplares similares
-
Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase
por: Buhren, Bettina Alexandra, et al.
Publicado: (2018) -
Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients
por: Gerber, Peter Arne, et al.
Publicado: (2012) -
Ingenol mebutate induces a tumor cell-directed inflammatory response and antimicrobial peptides thereby promoting rapid tumor destruction and wound healing
por: Braun, Stephan Alexander, et al.
Publicado: (2018) -
Dose- and time-dependent effects of hyaluronidase on structural cells and the extracellular matrix of the skin
por: Buhren, Bettina Alexandra, et al.
Publicado: (2020) -
Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients
por: Hilton, Said, et al.
Publicado: (2014)